The gastric cancer is the second most malignant tumor in the world. HER-2 is one of the key targets for the gastric cancer therapy. Anti-HER-2 antibodies like trastuzumab, exhibits the satisfactory therapeutic...
from Most Recent Articles: Journal of Nanobiotechnology https://ift.tt/2YEmdaa
via IFTTT
No comments:
Post a Comment